Matthew L. Sherman - 03 Oct 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role
EVP & Chief Medical Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Oct 2022
Net transactions value
-$48,455
Form type
4
Filing time
05 Oct 2022, 16:05:26 UTC
Previous filing
24 Jun 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $48,455 -2,587 -3.4% $18.73 74,297 03 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.